EDLUAR (zolpidem tartrate sublingual tablets)

With EDLUAR, your patients can let sleep being

Let sleep begin...

EDLUAR™, the sublingual tablet that contains the #1 prescribed sleep agent - zolpidem tartrate¹

"Sleep disturbances often go unrecognized and untreated." ²

• EDLUAR (zolpidem tartrate sublingual tablets)
  CIV is indicated for the short-term treatment of insomnia characterized by difficulties with sleep initiation.
• EDLUAR sublingual tablet is convenient
  to take. It dissolves under the tongue
  without water or any liquids
• EDLUAR offers the efficacy and safety profile of zolpidem tartrate
• EDLUAR offers instant savings on eligible patient copays

When the problem is sleep-onset insomnia, EDLUAR sublingual tablets may provide an effective way for your patients to get to sleep.

Learn More »

References: ¹ IMS Health, NPA. Monthly Rx. January to June 2009.

² Rosenberg R. Sleep Maintenance Insomnia: Strengths and Weaknesses of Current Pharmacologic Therapies. J Clin Psychiatry. 2006; 49-56

• About EDLUAR
• Prescription and Dosing
• Safety Information
• HCP FAQs
• Patient Savings Program
• For Pharmacists

Please See Full Prescribing Information.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.

MEDA Pharmaceuticals

• Home
• Please See Full Prescribing Information
• About MEDA
• Contact MEDA
• Privacy Policy